Allergology International

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

所有署名作者应实质性参与研究设计、数据收集或结果解读，撰写或批判性修改稿件并批准最终提交版本。 模型中文摘要

All people listed as authors of the manuscript should have contributed substantially to study planning, data collection, or interpretation of results and have written or critically revised the manuscript and approved its final submitted version. Describe each individual's contribution to the work in a short statement of authors' contributions on the title page.Statement example: AB, CD, and EF des…

每位列于标题页的作者必须使用ICMJE利益冲突披露表声明任何可能构成利益冲突的经济支持或关系。 模型中文摘要

Each author who is listed on the title page must declare any financial support or relationships that may pose a conflict of interest, using the ICMJE COI Disclosure form. The corresponding author is required: 1) to confirm whether all authors have filled out the form, 2) to write the COI statement covering all the authors' statements in the title page of the manuscript, 3) to submit to the journal…

文章应声明研究资助来源，包括资助方名称及其在研究设计、数据收集分析和解读、报告撰写中的作用（如有）。 模型中文摘要

Articles should declare sources of support for the work, including sponsor names along with explanations of the role of those sources, if any, in study design; collection, analysis, and interpretation of data; writing the report; or a statement declaring that the supporting source had no such involvement.

作者必须声明研究方案已获得适当组成的伦理委员会（如所在机构）批准。 模型中文摘要

Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee (e.g., of the institution within which the work was undertaken).

被接受的论文版权归日本过敏学会所有，所有作者须签署版权转让表，签署前须获得使用受版权保护或已发表材料的许可。 模型中文摘要

Papers accepted for publication become copyrighted by the Japanese Society of Allergology, and all authors will be asked to sign a transfer of copyright form. In signing the transfer of copyright, it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the Copyright Transfer Form and …

本刊所有同行评审研究论文均以开放获取形式发表，作者无需支付开放获取费用，由日本过敏学会承担。 模型中文摘要

Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format, immediately after publication. Authors do not incur any publication charges for open access: the Japanese Society of Allergology will pay to make the article open access.A CC user…

本刊采用单盲同行评审，所有稿件至少送两名独立专家评审，编辑对接受或拒绝的决定为最终决定。 模型中文摘要

This journal uses a single blind review process. All contributions are sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the decision regarding acceptance or rejection of articles. The Editor's decision is final. The Editor may decide to reject manuscripts without sending them out for peer review. For more information…

提交的稿件将由CrossCheck（由iThenticate提供支持）查重软件进行检查。 模型中文摘要

Submitted manuscripts will be checked by CrossCheck (powered by iThenticate), the plagiarism checker software.

曾在预印本服务器上发表的文章可以投稿，作者需在投稿信中注明预印本服务器名称和URL。 模型中文摘要

Articles previously published on preprint servers can be submitted. Authors need to mention the name of preprint server and the URL in the cover letter.

本刊遵循ICMJE临床试验注册指南，临床试验必须在公共试验注册机构注册。 模型中文摘要

This journal follows the International Committee of Medical Journal Editors (ICMJE) clinical trials registration guidelines. Registration Clinical trials must be registered in a public trials registry.